MGMT-methylated glioblastoma

Clinical trials for MGMT-methylated glioblastoma explained in plain language.

Never miss a new study

Get alerted when new MGMT-methylated glioblastoma trials appear

Sign up with your email to follow new studies for MGMT-methylated glioblastoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 5 Not yet recruiting 1 Completed 1

New drug combo shows promise in early brain cancer trial

Disease control Completed

This early-phase trial tested adding the targeted drug regorafenib to standard chemotherapy (temozolomide) with or without radiation for people with a newly diagnosed, aggressive type of brain cancer called glioblastoma. The study involved 21 participants and aimed to find the sa…

Matched conditions: MGMT-METHYLATED GLIOBLASTOMA

Phase 1 • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control

Last updated Jun 27, 2026 08:09 UTC

MGMT-methylated glioblastoma

Get alerted when new MGMT-methylated glioblastoma trials appear

New drug combo shows promise in early brain cancer trial